Details of the Drug-Related molecule(s) Interaction Atlas

General Information of Drug (ID: DMF5D1N)

Drug Name

Butylphosphonate Drug Info

Synonyms

Dibutyl phosphite; Dibutyl phosphonate; Phosphonic acid, dibutyl ester; Dibutoxyphosphine oxide; Mobil DBHP; Dibutyl hydrogen phosphonate; Di-n-butyl hydrogen phosphite; Dibutylfosfit; Phosphorous acid, dibutyl ester; Butyl phosphonate ((BuO)2HPO); Butyl alcohol, hydrogen phosphite; di-n-Butylphosphite; Dibutylfosfit [Czech]; NSC 2668; Dibutyl phosphite (VAN); Phosphonic Acid Dibutyl Ester; UNII-R149712Z1F; HSDB 2597; Dibutyl hydrogen phosphite (VAN); EINECS 217-316-1; R149712Z1F; Phosphorous acid, dibutyl ester (VAN); BRN 10997

Indication

Disease Entry	ICD 11	Status	REF
Discovery agent	N.A.	Investigative	[1]

Cross-matching ID

PubChem CID: 76839
ChEBI ID: CHEBI:41384
CAS Number: CAS 3321-64-0
TTD Drug ID: DMF5D1N

Molecule-Related Drug Atlas

Molecule Type:

DTT

Drug Status:

Clinical Trial Drug(s)

Discontinued Drug(s)

Download the Complete Related Drug List

Drug(s) Targeting Lipase unspecific (LIP)

Drug Name	Drug ID	Indication	ICD 11	Highest Status	REF
ApoC-III	DMBRQF5	N. A.	N. A.	Phase 3	[2]
GT-389255	DMLFCNY	Obesity	5B81	Discontinued in Phase 2	[3]
------------------------------------------------------------------------------------

Molecular Interaction Atlas of This Drug

Molecular Interaction Atlas

Download the Complete Interaction Atlas for Visualization in Cytoscape

Drug Therapeutic Target (DTT)

DTT Name	DTT ID	UniProt ID	MOA	REF
Lipase unspecific (LIP)	TT3GKN5	NOUNIPROTAC	Inhibitor	[1]

------------------------------------------------------------------------------------

References

1	How many drug targets are there Nat Rev Drug Discov. 2006 Dec;5(12):993-6.
2	An ABC of apolipoprotein C-III: a clinically useful new cardiovascular risk factor Int J Clin Pract. 2008 May;62(5):799-809.
3	Obesity drugs in clinical development. Curr Opin Investig Drugs. 2006 Apr;7(4):312-8.